Cell Therapies and Immunotherapy Conference Technical Program
...
| Day 1 July 20, 2022 | ||
| Start Time | End Time | |
| 9:00 AM | 10:00 AM | Registration |
| 10:00 AM | 10:10 AM | Welcome Remarks |
| 10:10 AM | 11:30 AM | Workshops |
| 10:10 AM | 10:40 AM | Lecture Part 1 |
| 10:40 AM | 11:10 AM | Lecture Part 2 |
| 11:10 AM | 11:30 AM | Q&A |
| 11:30 AM | 1:00 PM | Lunch Break (not provided) |
| 1:00 PM | 2:00 PM | Novel Immunotherapy Cell Chassis |
| 1:00 PM | 1:30 PM | Saar Gill, UPenn "CAR Macrophages" |
| 1:30 PM | 2:00 PM |
Joe Gold, Catamaran Bio |
| 2:00 PM | 2:30 PM | Stem Cell Biology and Engineering |
| 2:00 PM | 2:15 PM | Natesh Parashurama, The University at Buffalo "Human Pluripotent Stem Cell-Derived Liver Organogenesis" |
| 2:15 PM | 2:30 PM | Ying Chau, The Hong Kong University of Science and Technology "Artificial Antigen Presenting Cells for Ex Vivo T Cell Growth and Differentiation" |
| 2:30 PM | 3:00 PM | Coffee Break |
| 3:00 PM | 3:45 PM | Keynote: Megan Levings, UBC "Engineering regulatory T cells for tolerance" |
| 3:45 PM | 5:00 PM | Advances in Cancer Immunotherapy |
| 3:45 PM | 4:15 PM | Anusha Kalbasi, UCLA "Synthetic IL9R Signaling for T cell Therapy of Solid Tumors" |
| 4:15 PM | 4:45 PM | Chris Bond , Notch "The Promise of iPSC derived cell therapies" |
| 4:45 PM | 5:00 PM | Ravi Starzl, Firebreak Bio "Firebreak “Lock & Key” Antibodies Effective Against Broad Range of Sars-Cov-2 Variants" |
| Day 2 July 21, 2022 | ||
| Start Time | End Time | |
| 8:30 AM | 9:00 AM | Registration |
| 9:00 AM | 10:45 AM | T-cell Metaoblism & Tumor Microenvironment |
| 9:00 AM | 9:30 AM | Luca Gattinoni, University of Regensberg "Enhancing T cell-based immunotherapies by modulating cell metabolism" |
| 9:30 AM | 10:00 AM | Michael Berger, The Hebrew University of Jerusalem "Generating Metabolically Superior T Cells as a Novel Immunotherapy to Treat Solid Tumors" |
| 10:00 AM | 10:15 AM | Alexander Xu, "Spatially-Resolved Biomarkers of the Tumor Immune Microenvironment in Relapsed/Refractory Hodgkin's Lymphoma" |
| 10:15 AM | 10:30 AM | Ryan Wylie, "Biomaterial Based Strategies to Enhance the Efficacy of Immunotherapeutics Against Solid Tumors" |
| 10:30 AM | 10:45 AM | Abdullah Farooq, California Institute of Technology "Focused Ultrasound Control of Macrophage Immunotherapy Using Temperature Sensitive State Switches" |
| 10:45 AM | 11:15 AM | Coffee Break |
| 11:15 AM | 12:30 PM | Advances in CAR-T Cell Therapies |
| 11:15 AM | 11:45 AM | Avery Posey, University of Pennsylvania "Truncated O-glycosylation reshapes the tumor microenvironment in tumors and reveal tumor-restricted targets for CAR T-cells" |
| 11:45 AM | 12:00 PM | Tiara Boutte, Miltenyi "Miltenyi’s Translational Roadmap: Key Considerations for Cell Therapy Manufacturing" |
| 12:00 PM | 12:15 PM | Giuliano Bonfa "Improving CAR-T Cells Therapy with Smart T Exhaustion-Specific Synthetic Sensors" |
| 12:15 PM | 2:00 PM | Lunch Break (Not Provided) |
| 2:00 PM | 3:45 PM | Advances in Synthetic Biology and Biotechnology |
| 2:00 PM | 2:30 PM | Sungeun Kim, Amgen "TCR Discovery & preclinical models that evaluate efficacy and safety of TCR-T cell therapy" |
| 2:30 PM | 3:00 PM | Jim Johnston, Immpact "Logic-Gated CAR T cell Therapies" |
| 3:00 PM | 3:15 PM | Talar Tokatlian, A2Bio "A Modular Receptor System Exploits Tumor Deletions to Achieve Robust Tumor-Selective Cytotoxicity" |
| 3:15 PM | 3:30 PM | Fabio Caliendo, Massachusetts Institue of Technology "The Gene Sensor: A Platform for Sensing and Responding to Gene Expression in the Endogenous Locus" |
| 3:30 PM | 4:00 PM | Alan Epstein, University of Southern California "HuLym-1 DAP CAR-T - Hematological Malignancies" |
| 4:00 PM | 4:45 PM | Poster and Reception |
| Day 3 July 22, 2022 | ||
| Start Time | End Time | |
| 9:00 AM | 9:15 AM | Registration |
| 9:15 AM | 10:00 AM | Clive Svendsen, Cedars "Engineering stem cells to release growth factors for the treatment of neurological diseases" |
| 10:00 AM | 10:30 AM | Coffee Break |
| 10:30 AM | 11:00 AM | Systems Biology |
| 10:30 AM | 10:45 AM | Natesh Parashurama, The University at Buffalo FOXA1/2 Depletion Drives Global Reprogramming of Differentiation State and Metabolism in a Human Hepatic Cell Line and Human Stem Cell-Derived Hepatic Progenitor Cells |
| 10:45 AM | 11:00 AM | Juan Luis Blazquez Roman, Italian Institute of Technology "Drug-Set-Enrichment Analysis (DSEA) in the Identification of Drugs Able to Counteract CD8+ T-Cells Exhaustion" |
| 11:00 AM | 11:45 AM | Industry Panel |
| Amy Gilbert (Chair), Adaptive Biotech | ||
| Amritha Lewis, Adaptive Biotech | ||
| Sungeun Kim, Amgen | ||
| Tiara Boutte, Miltenyi | ||
| Sarah Davies, Atara | ||
| Agi Hamburger, A2 | ||
| Joe Gold, Catamaran | ||
| 11:45 AM | 1:15 PM | Lunch Break (Not Provided) |
| 1:15 PM | 2:15 PM | Next-Generation Cell-based Therapies |
| 1:15 PM | 1:45 PM |
Alena Gros, Vall D'Hebron |
| 1:45 PM | 2:15 PM | Cristina Puig-Saus University of Califonria - Los Angeles "CAR-T cell therapy targeting surface expression of TYRP1 for the treatment of patients with melanoma" |
| 2:15 PM | 2:50 PM | Roundtable Discussion (Academic & Industry) |
| 2:50 PM | 3:00 PM | Closing Remarks |